Strategies for Off-Patent Players Pricing pressures With multiple generic manufacturers expected to enter the market at launch, aggressive price competition is likely, particularly in countries where GLP-1 pricing remains high by international standards
For weight, GLP-1 and GLP-1 plus metformin consistently showed significant reductions compared with placebo, while metformin alone also retained a modest but significant effect
10.1126/science.1072994 Science 25 HlscherC
Nature 509:2404
Among the top 12, the biggest climbers were AstraZeneca, Eli Lilly, and Novo Nordisk
When treatments were initiated, mice had ad libitum access to food, water, and kaolin pellets